Bunka Christopher

CEO, Director, 10% OwnerLexaria Bioscience Corp. (LXRP) · full profile →Form 4 · filed Nov 10, 2020
Net Buying
Open-Market Buys
$40K
Open-Market Sells
$0
Net Open-Market Flow
$40K
Transactions
10
10 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 10, 2020Buy(P)6K$0.20$1K6.5M
Nov 10, 2020Buy(P)26K$0.19$5K6.5M
Nov 10, 2020Buy(P)10K$0.20$2K6.4M
Nov 9, 2020Buy(P)10K$0.21$2K6.4M
Nov 9, 2020Buy(P)7K$0.20$1K6.4M
Nov 9, 2020Buy(P)38K$0.22$8K6.4M
Nov 9, 2020Buy(P)10K$0.20$2K6.4M
Nov 9, 2020Buy(P)22K$0.20$4K6.4M
Nov 9, 2020Buy(P)8K$0.20$2K6.4M
Nov 6, 2020Buy(P)60K$0.21$13K6.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001103780-20-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about LXRP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001103780-20-000004"
Ask your agent
Use Arkolith to summarize insider buying and selling at Lexaria Bioscience Corp.
over the last 90 days and cite the filings.